Clinical Trial Update: Telmisartan Versus Ramipril After Acute Coronary Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing telmisartan to ramipril in patients after acute coronary syndrome to evaluate outcomes; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome
• Myocardial Infarction

Drugs mentioned

• Ramipril (ramipril)
• Telmisartan (Telmisartan)

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: Acute Coronary Syndrome, Myocardial Infarction | Phase 4 | Status: UNKNOWN